Dolby Laboratories (NYSE:DLB) Issues Q2 2026 Earnings Guidance

Dolby Laboratories (NYSE:DLB) issued an update on its second quarter 2026 earnings guidance on Friday morning. The company provided earnings per share guidance of 1.290-1.440 for the period, compared to the consensus earnings per share estimate of 1.240. The company issued revenue guidance of $375.0 million-$405.0 million, compared to the consensus revenue estimate of $380.6 million. Dolby Laboratories also updated its FY 2026 guidance to 4.300-4.450 EPS.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Rosenblatt Securities reissued a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 29th. Barrington Research lowered their price objective on shares of Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating for the company in a research report on Monday, January 26th. Finally, Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Dolby Laboratories currently has a consensus rating of “Moderate Buy” and an average price target of $90.75.

Dolby Laboratories Stock Up 1.8%

NYSE:DLB opened at $64.19 on Friday. The company has a market cap of $6.13 billion, a price-to-earnings ratio of 25.88 and a beta of 0.88. The company has a fifty day simple moving average of $65.07 and a two-hundred day simple moving average of $68.88. Dolby Laboratories has a 52 week low of $60.14 and a 52 week high of $85.49.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Thursday, January 29th. The electronics maker reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.99 by $0.07. The company had revenue of $346.71 million during the quarter, compared to the consensus estimate of $341.26 million. Dolby Laboratories had a net margin of 17.97% and a return on equity of 11.49%. The firm’s quarterly revenue was down 2.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.14 earnings per share. On average, analysts expect that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 18th. Investors of record on Tuesday, February 10th will be given a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, February 10th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.2%. Dolby Laboratories’s dividend payout ratio is 54.75%.

Insider Buying and Selling at Dolby Laboratories

In related news, CEO Kevin J. Yeaman sold 36,699 shares of the stock in a transaction on Monday, November 24th. The stock was sold at an average price of $66.91, for a total transaction of $2,455,530.09. Following the completion of the sale, the chief executive officer directly owned 114,725 shares of the company’s stock, valued at $7,676,249.75. This trade represents a 24.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP John D. Couling sold 7,273 shares of Dolby Laboratories stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $68.75, for a total transaction of $500,018.75. Following the completion of the sale, the senior vice president directly owned 108,065 shares in the company, valued at approximately $7,429,468.75. The trade was a 6.31% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 137,120 shares of company stock valued at $9,184,809. Insiders own 37.93% of the company’s stock.

Key Headlines Impacting Dolby Laboratories

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Company raised FY‑2026 and Q2 guidance well above Street estimates (FY EPS 4.30–4.45 vs. consensus ~3.79; Q2 EPS 1.29–1.44). The stronger outlook is the main catalyst supporting the stock today.
• Positive Sentiment: Dolby announced a quarterly dividend of $0.36 per share (yield ~2.3%), which can attract income-oriented investors and support the share price around the ex‑dividend date.
• Positive Sentiment: Rosenblatt reaffirmed a “Buy” rating with an $85 price target, adding analyst support and upside narrative for investors. Benzinga
• Neutral Sentiment: Q1 results beat consensus on EPS ($1.06 vs. ~$0.99) and revenue (~$346.7M vs. ~341M), indicating operational resilience even as some metrics softened. PR Newswire
• Negative Sentiment: Revenue and EPS were down year-over-year (revenue down ~2.8%), driven by weaker licensing, which triggered an after‑hours selloff after the print and remains a near-term risk. Zacks
• Negative Sentiment: Operational and cash-flow pressures were noted (operating profit and net income declined; temporary negative operating cash flow and higher capex flagged by third‑party summaries), which could weigh on near‑term margins and investor sentiment. Quiver Quant

Institutional Trading of Dolby Laboratories

A number of institutional investors have recently added to or reduced their stakes in DLB. State Street Corp lifted its stake in Dolby Laboratories by 8.7% in the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after buying an additional 180,072 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of Dolby Laboratories by 51.8% in the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after acquiring an additional 592,282 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Dolby Laboratories by 8.2% during the third quarter. Dimensional Fund Advisors LP now owns 1,149,927 shares of the electronics maker’s stock valued at $83,220,000 after acquiring an additional 87,202 shares during the last quarter. Squarepoint Ops LLC increased its position in Dolby Laboratories by 37.2% during the 3rd quarter. Squarepoint Ops LLC now owns 516,700 shares of the electronics maker’s stock worth $37,394,000 after purchasing an additional 140,201 shares in the last quarter. Finally, Bank of America Corp DE raised its stake in Dolby Laboratories by 3.1% in the 3rd quarter. Bank of America Corp DE now owns 511,891 shares of the electronics maker’s stock valued at $37,046,000 after purchasing an additional 15,237 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.